The area around Cambridge, known as the Cambridge Cluster, is a global hub for both scientific research and its commercialisation. Home to some of the greatest scientific and technological advances in history, it comprises Europe’s largest, and what is considered by many to be its most successful, technology cluster.

Over the past 50 years the University of Cambridge, together with its colleges, has played a central role in establishing and growing the Cambridge Cluster. Starting with Trinity College establishing the UK’s first ever science park in 1970, the Cluster has grown so that there are now more than 20 research parks in the area.

These parks have provided a home for the constant flow of innovation, staff and graduates from the University of Cambridge to companies in the Cambridge Cluster, which has grown from 20 companies employing 100 people in 1978 to more than 4,000 knowledge-intensive companies employing over 58,000 people and turning over more than £11 billion every year, according to data compiled by the University.

The Cambridge Cluster is home to a number of world-leading businesses that have emerged throughout the last two decades, including Abcam, ARM, Autonomy, Aveva, Cambridge Antibody Technology, CSR, Domino Printing, Solexa and Virata.

With its highly developed technology ecosystem, Cambridge hosts a diverse group of scientists, technical pioneers and leading engineering firms, complemented by a well-established network of entrepreneurs and angel investors. Several of these are on CIC’s Advisory Panel.

The Cambridge Cluster continues to grow, with investment in new research facilities and infrastructure, including the £1 billion North West Cambridge development, and the biomedical campus at Addenbrooke’s Hospital. World leading companies such as Apple, Microsoft, AstraZeneca and Amazon have established research and development centres in order to tap into the innovation and talent present here.

It is in this context that CIC is building a business headquartered in the Cambridge Cluster and focused on investing in intellectual property rich companies arising from both the University of Cambridge and the Cambridge ecosystem.